3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trialCarel W. le Roux, Aila Rissanen, Rafael Violante Ortíz et al.|The Lancet|2017Cited by 843
PIONEER 1: Randomized Clinical Trial of the Efficacy and Safety of Oral Semaglutide Monotherapy in Comparison With Placebo in Patients With Type 2 DiabetesVanita R. Aroda, Ömür Tabak, Julio Rosenstock et al.|Diabetes Care|2019Cited by 465
Therapeutic vs. Suprapharmacological Metformin Concentrations: Different Effects on Energy Metabolism and Mitochondrial Function in Skeletal Muscle Cells in vitroKasja Pavlović, Nebojša Lalić|Frontiers in Pharmacology|2022Cited by 22